Genesis Bioventures Inc (1084966) SEC Filing 8-K Material Event for the period ending Wednesday, October 3, 2007

Abviva Inc

CIK: 1084966

View differences made from one to another to evaluate Abviva Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abviva Inc.


Assess how Abviva Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1084966
Form Type: 8-K Corporate News
Accession Number: 0001365701-07-000032
Submitted to the SEC: Wed Dec 19 2007 8:25:59 PM EST
Accepted by the SEC: Thu Dec 20 2007
Period: Wednesday, October 3, 2007
Industry: Medical Laboratories
  1. Event for Officers
  2. New Agreement
  3. Unregistered Sales

External Resources:

Bookmark the Permalink: